Scholar Rock: Likely Approval In SMA Plus Obesity Data In 2025 Intrigue, But Price Too High
I analyze Scholar Rock's promising Phase 3 results for SMA drug, but warn of financial challenges and recommend a Hold rating ...
EurekAlert!2d
GLP-1 RA medications safe and very effective for treating obesity in adults without diabetes
A systematic review of randomized controlled trials (RCTs) assessed the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and co-agonists for obesity in adults without ...
The Brighterside of News on MSN14d
Ozempic: A new hope for opioid and alcohol addiction treatment
The prevalence of substance use disorders, such as opioid and alcohol use disorders, has created a significant public health ...
NBC News27d
Obesity dipped in U.S. adults last year for the first time in more than a decade
(Those are slightly higher shares than the estimate from the Center s for Disease Control and Prevention, which says around 40% of U.S. adults had obesity from 2021 ... at the New York University ...
Health.com27d
Study Finds Nearly Half of People on Obesity Drugs Drink Less—But Do Scientists Know Why?
Some anti-obesity medications, including GLP-1s, may prompt people to drink less alcohol, new research has found ... too soon to add substance use treatment to that list of benefits, said study ...
WBBM Radio Chicago on MSN6d
Drugs may reverse America's obesity crisis in 2025
For the first time in a decade, U.S. obesity rates have begun to decline, raising hopes that the nation may be turning a ...
Mint22d
US obesity rate declines for the first time in a decade, weight-loss drugs play key role
For the first time in a decade, the United States is seeing a slight decline in obesity rates. A new study published in ... BMI dropped from 30.24% in 2021 to 30.21% in 2023, indicating a similar ...
Psychology Today17d
Can the New Weight-Loss Drugs Also Fight Depression?
The history of breakthrough weight loss medicines is riddled with tragic results. Based on the histories of phen-fen and rimonabant, many are concerned about GLP-1 agonists. Notably, the mechanisms of ...
The Advocate20d
Guest column: The rise in obesity heralds a rising liver health problem. And that can be deadly.
Despite trying interventional radiation, aggressive tumor growth and other severe symptoms made getting a chance for a new organ ... We need obesity prevention and treatment programs, including ...
manilatimes1d
MoonLake initiates three new clinical trials and further expands the portfolio of indications for the Nanobody® sonelokimab
New trials in three new indications have been initiated with the Nanobody® sonelokimab: Phase 3 VELA-TEEN trial in adolescent ...
Newsweek23d
Americans Are Less Obese Than Before
Across a sample of nearly 17 million adults in a new JAMA Health Forum study, mean population body mass index grew from 2013 to 2021 ... to treatment options. A lot needs to be done for obesity ...
The Indian Express19d
WHO scientists endorse weight loss drugs for controlling obesity: What does it mean for therapies?
In a first, scientists at the World Health Organisation (WHO) have endorsed a new class of medicines known ... doctors prescribed it off-label for obesity, sparking a social media frenzy and supply ...